# Improvement Effect of Lacosamide and Levetiracetam on Cognitive in Alzheimer's Disease Patients With Epilepsy

> **NCT05969054** · PHASE4 · UNKNOWN · sponsor: **Xiangya Hospital of Central South University** · enrollment: 140 (estimated)

## Conditions studied

- Alzheimer Disease 3
- Epilepsy

## Interventions

- **DRUG:** Lacosamide 100 mg
- **DRUG:** Levetiracetam 250mg

## Key facts

- **NCT ID:** NCT05969054
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-05
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2023-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05969054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05969054, "Improvement Effect of Lacosamide and Levetiracetam on Cognitive in Alzheimer's Disease Patients With Epilepsy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05969054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*